Secondary tabs
Contact details
Emma-Jane Loveridge
Main
Publications
Data source publications
- Defining clinical subtypes of adult asthma using electronic health records: Analysis of a large UK primary care database with external validation
- Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist Care
- Impact of COVID-19 pandemic on asthma exacerbations: Retrospective cohort study of over 500,000 patients in a national English primary care database
- Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
- Data-Resource Profile: United Kingdom Optimum Patient Care Research Database
Studies
List of studies that have been conducted using the data source
- Underuse of beta-blockers in patients with heart failure and COPD
- Real life effectiveness and cost impact evaluation of fixed dose combination fluticasone propionate/formoterol (Flutiform®) compared to fluticasone propionate/salmeterol (Seretide®) (eFFectiveness)
- Inhaled Corticosteroid and Real Life unlicensed Spacer Use (stage 1) (ICARUS 1)
- Incidence of oral thrush in COPD patients prescribed ICS as part of ICS/LABA therapy
- Benefits of high dose ICS in patients with asthma and high blood eosinophil counts
- Real-life effectiveness evaluation of budesonide/formoterol (BF) Spiromax for the management of asthma and COPD
- ICARUS: Inhaled Corticosteroid And Real life Unlicensed Spacer use – stage 2 (ICARUS 2)
- Burden of disease in patients with COPD and high blood eosinophil counts (High eosinophils and COPD)
- Training requirements to master inhaler devices available in real-life clinical practice (TMID)
- Exploring differences in asthma disease severity and pathways: variation by ethnicity and socioeconomic status
- Effectiveness of triple therapy vs. dual bronchodilation in COPD (Effectiveness of triple therapy in COPD)
- Decline In lung-function Among Patients with chronic obstructive Lung disease On maintenance therapy (DIAPLO)
- Real world glycemic effectiveness of linagliptin (Tradjenta®) among type 2 diabetes mellitus adults by age and renal function.
- Exogenous sex steroid hormones and asthma in females: a population-based retrospective cohort study using primary care data
- Asthma and Type 2 Comorbidities - Real-life Characterisation of Patients with Active Asthma and Type 2 Asthma Comorbidities
- Investigating the possible role of BLood eosinophil counts in guiding ANti-inflammatory treatment of COPD exAcerbations (BLANCA)
- The role of adherence to inhaled corticosteroids in the relationship between blood eosinophilia and asthma control
- Asthma management in France and the United Kingdom
- Studying the value of fractional exhaled Nitric Oxide and blood eosinophils as biomarkers in predicting which patients will suffer from more frequent asthma exacerbations, and evaluating the subsequent healthcare resource utilisation (Assessing RIsk of exAcerbation (ARIA))
- Evaluation of the undertreatment and disease outcomes for patients with coexisting Heart Failure and Chronic Obstructive Pulmonary Disease
- Historical matched-cohort study assessing whether the use of inhaled corticosteroids shortens time to first diagnosis or accelerates the progression of side effects compared to non-ICS therapies in patients with Chronic Obstructive Pulmonary Disease. (ICS use in COPD patients and risk of side effects)
- Epidemiological trends of Alpha1-antitrypsin deficiency (AATD) in the UK: prevalence and incidence from 1990 to 2015
- Use of degarelix among patients with prostate cancer in daily practice
- Evaluation of Current Implementation of BTS/NICE Clinical Quality Standards In Community Acquired Pneumonia (CAP): A UK retrospective follow-up study
- IDENTIFYING OPPORTUNITIES FOR EARLIER DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS IN ROUTINE CARE IN THE UK: A RETROSPECTIVE CLINICAL COHORT STUDY (OPPORTUNITIES FOR EARLIER IPF DIAGNOSIS)
- Characterising Patient Pathways to the Diagnosis of Idiopathic Pulmonary Fibrosis: Real World Data Study
- Burden of cough in primary care
- Effectiveness of Dymista® in patients with allergic rhinitis and asthma
- Impact of obstructive sleep apnea diagnosis on healthcare resource utilization in patients with obstructive lung disease
- Validation of real-life asthma research endpoints (Real-life asthma endpoint validation)
- COMPARABILITY OF POPULATION DEFINITIONS WITHIN & BETWEEN GLOBAL DATABASES – DEVELOPING TOOLS FOR OBSERVATIONAL RESEARCH (ACO Population Definitions)
- A prediction model for future exacerbation risk in children
- Longitudinal systemic corticosteroid utilization in the UK, 1990-2018
- Eosinophilic asthma phenotypes and associated clinical outcomes
- Effectiveness of Fostair® (ICS/LABA) vs. dual bronchodilation (LABA/LAMA) in COPD (FELICITI)
- The Impact of Exacerbation Burden on Lung Function Trajectory in a Broad Asthma Population and Severe Asthma Population (Exacerbation and lung function trajectory)
- The Characterization and Comparison of Eosinophilic and Non-eosinophilic Phenotypes of Severe Asthma
- Impact of Optimum Patient Care’s clinical review service (Impact of OPC)
- Hidden Severe Asthma in Primary Care versus ISAR Cohort
- A pragmatic, cluster randomized trial evaluating the impact of an enhanced adherence package (dual bronchodilator+add-on+app) on time to treatment failure and other clinical outcomes in exacerbating COPD patients with poor adherence to mono or dual therapy over one year (MAGNIFY)
- EXPLORING THE BIDIRECTIONAL RELATIONSHIP BETWEEN DATABASE MARKERS OF ASTHMA TREATMENT ADHERENCE AND ASTHMA-RELATED OUTCOMES (ICS ADHERENCE & ASTHMA CONTROL OUTCOMES)
- Similarity-based approaches to identifying risk of future asthma attack using UK primary care data
- Addressing the burden of respiratory disease in General Practice: A real-life implementation study focusing on high risk asthma and COPD patients
- ADDITION OF ANTIBIOTICS TO USUAL CARE MANAGEMENT OF ASTHMA EXACERBATIONS: A REALLIFE COMPARATIVE EFFECTIVENESS STUDY
- Comparative safety of extrafine beclometasone fixed dose combinations (FDC) and fluticasone FDC in COPD
- Implications of ICS withdrawal in the real-life management of COPD
- The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients
- Development, validation, utility and economic assessment of a flexible, individualized risk prediction e-tool for exacerbation in patients with severe asthma (Severe asthma risk prediction)
- Drug utilisation and incident rates of adverse events in children with sialorrhoea who are treated with glycopyrronium (Glyco Sialorrhoea)
- Impact of COVID-19 on Asthma Exacerbations (Asthma Attacks During COVID-19)
- Predicting Asthma Attacks in Primary Care with Machine Learning
- Development of a predictive model algorithm to identify patients with hypophosphatasia, using Optimum Patient Care Record Database in United Kingdom
- An observational cohort study to describe intermittent OCS utilisation and its association with adverse outcomes and healthcare resource use and costs in asthma using the OPCRD and CPRD databases. (The burden of intermittent OCS use in asthma)
- Twenty years of COPD primary care: Patterns of management of high-risk COPD and opportunities for optimising care in the United Kingdom 2000-2019: Study Protocol (CONQUEST UK Opportunity Analysis)
- A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with xerostomia in primary care settings using Optimum Patient Care Research Database in United Kingdom.
- Characteristics, Treatment and Healthcare Resource Utilisation in Patients diagnosed with Neuropathic or Chronic Pain Using Primary Care Electronic Health Records in the United Kingdom (UK)
- Determining the prevalence of severe asthma in children in UK primary care
- A retrospective observational study on effectiveness of influenza vaccine Supemtek® compared to other vaccines in adults aged 18 years and above in the United Kingdom – a feasibility study
- Closing the loop for Fabry disease and Pompe disease in the UK (RARE)
- Real-world use of Breztri/Trixeo for the management of COPD in a UK primary care population
- The UK nationwide cardiorespiratory impact of the COVID-19 pandemic
- Cardiopulmonary risk model for patients with chronic obstructive pulmonary disease
- Exacerbation history in COPD patients prior to diagnosis and subsequent treatment and outcomes
- Redefining severe asthma to high-risk asthma: Analysis of real-world data to investigate patients who are at high risk of exacerbations, worsening of symptoms, and a loss of asthma control over time.
- Patient characteristics and treatment pathways in patients with COPD initiated on ICS/LABA/LAMA and LABA/LAMA treatment
- Understanding high-risk COPD: Analysis of real-world data to investigate characteristics and outcomes in patients with high-risk COPD. (OPRI 2306: High Risk COPD)
- AI-powered stratification of autoimmune diseases
- Breathlessness Rapid Evaluation and THErapy (BREATHE)
- Depicting real-life treatment journeys for patients affected with an immune-inflammatory condition and treated with methotrexate
- OPCRD ADEPT application Study Protocol
- Disease trajectory and treatment escalation in severe asthma: A retrospective analysis of data from the Optimum Patient Care Research Database (OPCRD)
- The development and evaluation of prognostic models to predict biologic eligibility in asthma
- Validity of using prescription records to identify patient comorbidities
- Assessing the impact of earlier access to biologics on remission and natural course of asthma (GLEAM)